share_log

双成药业(002693.SZ):产品醋酸奥曲肽注射液美国市场目前还未上市销售

Hainan Shuangcheng Pharmaceuticals (002693.SZ): At present, the product Acotiamide Acetate Injection has not yet been launched for sale in the USA market.

Gelonghui Finance ·  Jun 13 04:48

On June 13th, Gelonhui reported that an investor asked Hainan Shuangcheng Pharmaceuticals (002693.SZ) on the investor interaction platform, "Has the Acetate Ornipressin Injection ANDA obtained FDA approval and been sold in the US market?" The company responded that its product, Acetate Ornipressin Injection, has not yet been launched for sale in the US market.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment